⌘K

16:01:00·1509d

PRReleasevia Quantisnow

Oyster Point Pharma Reports First Quarter 2022 Financial Results and Recent Business Highlights

ByQuantisnow·Wall Street's wire, on your screen.

OYST· Oyster Point Pharma Inc.

Health Care

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7
SEC Form SC 13G/A filed by Oyster Point Pharma Inc. (Amendment)
SEC Form SC 13G/A filed by Oyster Point Pharma Inc. (Amendment)
SEC Form 15-12G filed by Oyster Point Pharma Inc.
Oyster Point Pharma Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits (Amendment)